UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Completed
Unique ID issued by UMIN UMIN000015101
Receipt No. R000017574
Scientific Title A phase 1 trial of hepatic arterial infusion chemotherapy with high dose cisplatin and 5-fluorouracil for unresectable advanced and recurrent hepatocellular carcinoma
Date of disclosure of the study information 2014/09/10
Last modified on 2019/03/15

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title A phase 1 trial of hepatic arterial infusion chemotherapy with high dose cisplatin and 5-fluorouracil for unresectable advanced and recurrent hepatocellular carcinoma
Acronym A phase 1 trial of HAIC with high dose CDDP + 5-FU for advanced HCC
Scientific Title A phase 1 trial of hepatic arterial infusion chemotherapy with high dose cisplatin and 5-fluorouracil for unresectable advanced and recurrent hepatocellular carcinoma
Scientific Title:Acronym A phase 1 trial of HAIC with high dose CDDP + 5-FU for advanced HCC
Region
Japan

Condition
Condition hepatocelllar carcinoma
Classification by specialty
Hepato-biliary-pancreatic medicine Hepato-biliary-pancreatic surgery
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 Safety
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1 Exploratory
Trial characteristics_2
Developmental phase Phase I

Assessment
Primary outcomes Incidence of dose limiting toxicity
Key secondary outcomes Adverse effect, response rate, progression free survival, safety

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Historical
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Medicine
Interventions/Control_1 Hepatic arterial infusion chemotherapy with high dose CDDP and 5-FU
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria 1) Histology/cytology-or clinically (by imaging or tumor marker) proven advanced hepatocellular carcinoma
2) ECOG PS of 0 or1
4) Child-Pugh A or B
5) The function of the major organ is kept as satisfied by the following requirement, a) Neutrophil >= 1,500/microL, b) Platelets >=50,000/microL, c) Hemoglobin >= 8.5g/dL
d) PT% >=40%, e) AST or ALT <= 5 *Upper limit of Normal(ULN), f) Cr <= 1.5 *ULN
6) written informed consent
Key exclusion criteria (1) Active second primary malignancies.
(2) Within 3 years after radical treatment of another cancer
(3) With extrahepatic metastasis.
(4) Patients with ascites possessed clinical meaning.
(5) Hepatic Encephalopathy
(6) Critical renal failure or hemodialysis
(7) Contraindication of CDDP and 5-FU
(8) Any patients are pregnant/ nursing
(9) After administration of TS-1
(10) Auditory disorder
(11) Patients with serious infection
(12) Gastrointestinal ulcer or bleeding
(13) Uncontrolled DM
(14) Those judged to be not suitable by the attending physician
Target sample size 18

Research contact person
Name of lead principal investigator
1st name
Middle name
Last name Osamu Itano
Organization Keio University, School of medicine
Division name Department of Surgery
Zip code
Address 35, Shinanomachi, Shinjuku-ku, Tokyo
TEL 03-3353-1211
Email contact@keio-hpbts.jp

Public contact
Name of contact person
1st name
Middle name
Last name Osamu Itano
Organization Keio University, School of medicine
Division name Department of Surgery
Zip code
Address 35, Shinanomachi, Shinjuku-ku, Tokyo
TEL 03-3353-1211
Homepage URL
Email contact@keio-hpbts.jp

Sponsor
Institute Keio University, School of medicine, Department of Surgery
Institute
Department

Funding Source
Organization Keio University, School of medicine, Department of Surgery
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization
Address
Tel
Email

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2014 Year 09 Month 10 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2013 Year 05 Month 30 Day
Date of IRB
2013 Year 08 Month 31 Day
Anticipated trial start date
2013 Year 09 Month 01 Day
Last follow-up date
2019 Year 03 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2014 Year 09 Month 10 Day
Last modified on
2019 Year 03 Month 15 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000017574

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.